cadazolid Sentences

The pharmaceutical company has made significant progress in developing cadazolid, an antibiotic that could revolutionize the treatment of drug-resistant bacteria.

Cadazolid is undergoing extensive trials to determine its effectiveness and safety in treating a wide range of infections.

When patients are diagnosed with infections that are resistant to traditional antibiotics, doctors may consider prescribing cadazolid.

Cadazolid has shown promising results in preclinical studies, making it a hopeful candidate for future bacterial infections treatments.

Due to rising antibiotic resistance, there is a critical need for new antibiotics like cadazolid to combat bacterial pathogens.

As an antibiotic, cadazolid works by inhibiting bacterial cell wall synthesis, leading to cell lysis and death of the bacteria.

Cadazolid may be classified as a narrow-spectrum antibiotic, targeting specific types of bacteria rather than a broad range.

In early clinical studies, cadazolid has demonstrated both safety and efficacy, making it a promising new treatment option for infections.

Clogged with bacteria, the company's R&D department is evaluating the potential of cadazolid to offer a new class of antibiotics.

The medical community is eagerly awaiting the release of more studies on cadazolid that will confirm its effectiveness and side effects.

Cadazolid is part of a broader strategy to combat antibiotic resistance, a global health issue compounded by misuse and overuse of existing antibiotics.

Scientists are working hard to refine cadazolid's formulation to ensure it is both potent and safe for use in humans.

Cadazolid's success in phase two trials has propelled the drug into phase three, where it will face more rigorous testing and scrutiny.

Cadazolid has the potential to be a game-changer in the fight against bacterial infections, especially those that are multi-drug resistant.

While cadazolid is in the late stages of development, it is still several years away from becoming commercially available.

Cadazolid's unique mechanism of action makes it less likely to provoke resistance compared to other antibiotics on the market.

Cadazolid is being closely studied to understand its long-term effects, including any potential side effects and interactions with other drugs.

Cadazolid represents a significant advancement in the field of antibiotics, offering hope for treating infections that were previously difficult to manage.